OPTIM: A randomized phase II study on the OPTimization of IMmunotherapy in squamous carcinoma of the head and neck - AIO-KHT-0117V. Gruenwald,J. Alt,M. Tometten,M. Haenel,P. Ivanyi, G. Schuch,K. Klinghammer,K. Gutsche,J. Hasenkamp, G. Hapke, M. Maenz,W. Weichert,D. A. HahnANNALS OF ONCOLOGY(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要